Ralph Snyderman
Lua error in package.lua at line 80: module 'strict' not found. Ralph Snyderman is Chancellor Emeritus at Duke University and James B. Duke Professor of Medicine. He served as Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to July 2004. During this period, he oversaw the development of the Duke University Health System, one of the most successful integrated academic health systems in the country and served as its first President and Chief Executive Officer. Dr. Snyderman has been widely recognized for his contributions to the development of more rational, effective and compassionate models of health care. He led the development of Prospective Health Care, a model of personalized care based on personalized health planning. Dr. Snyderman was the recipient of the 2012 David E. Rogers Award from the Association of American Medical Colleges who recognized him as "The Father of Personalized Medicine."
He was also a prominent researcher in the field of inflammation and has won many awards for his seminal work on leukocyte chemotaxis. Dr. Snyderman discovered C5a, a major chemotactic factor responsible for white blood cell accumulation and vascular permiability at sites of inflammation. He also discovered chemotactic lymphokines,anticipating the field of chemokine research.
Dr. Snyderman has played a prominent role in the leadership of important national organizations as the Association of American Physicians (president in 2003-2004) and the Association of American Medical Colleges (chair in 2001-2002). In February 2009, he chaired the Institute of Medicine’s Summit on Integrative Medicine and the Health of the Public, which focused on strategies for effective health care reform that puts the patient at the center of care. He is a member of the National Academy of Medicine and the American Academy of Arts & Sciences and serves on the Department of Veterans Affairs Special Medical Advisory Group.
In 1987, Dr. Snyderman joined Genentech, Inc., a biomedical technology firm in San Francisco, CA, as vice president for medical research and development. A year later he was promoted to senior vice president. While at Genentech, he led the development and licensing of important therapeutics and supervised 300 staff members working in pharmacology, clinical research and regulatory affairs.
Snyderman has been the recipient of many honors and awards. In 2003, he received the Ellis Island Medal of Honor presented to outstanding Americans who have distinguished themselves among their specific ethnic groups and have made significant contributions to our country. He was awarded the first Bravewell Leadership Award for outstanding achievements in the field of integrative medicine in 2003. Dr. Snyderman received the 2007 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition for his efforts in advancing predictive and targeted therapies on a national scale. In May 2008, he received the prestigious Industrial Research Institute (IRI) Medal for his outstanding accomplishments in technological innovations that contribute to the development of industry and to the benefit of society. In November 2008, Dr. Snyderman was awarded Frost & Sullivan’s 2008 North American HealthCare Lifetime Achievement Award for his pioneering spirit and contributions to medicine. And, in March 2009, he received the Triangle Business Journal’s Healthcare Lifetime Achievement Award. In February 2010, Procter & Gamble named Dr. Snyderman an honorary member of the Victor Mills Society for his leadership and impact on innovation. He was awarded the Clinical Research Forum’s 2010 Leadership in Academic Health Centers award. Dr. Snyderman was recognized as a Bioscience Leader Emeriti by the North Carolina Association for Biomedical Research in 2010 honoring North Carolina research leaders for their outstanding leadership in research and development and in the transformation of the state through scientific discovery and innovation. In October 2011, Snyderman received the William B. Anlyan, MD, Lifetime Achievement Award recognizing his contributions to Duke University Medical Center. In 2012, he received the David E. Rogers Award from the Association of American Medical Colleges for his contributions to improving the nation's health. In January 2016, Dr. Snyderman received the Personalized Medicine World Conference's Pioneer Award.
A graduate of Washington College in Chestertown, Maryland, Dr. Snyderman received his MD, magna cum laude, in 1965 from SUNY Downstate Medical Center. He served his internship and residency in medicine at Duke and later worked as a Public Health Officer doing research in immunology at the NIH. Dr. Snyderman has contributed to almost 400 scientific manuscripts.
